Diaspora led pharma gets grant for research against Parkinson's
Major funding, totaling 1.49 million dollars, for pioneering research to treat Parkinson's disease, was secured from the Michael J. Fox Foundation, by the Greek-American-owned pharmaceutical company Kannalife.
- Published in Diaspora